Trinity Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Trinity Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11493
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Trinity Health (Trinity) formerly known as CHE Trinity Health, is a national Catholic health care organization that provides health care solutions in the US. It operates through a network of hospitals, health care services, and advocate partnerships at community, regional, and national levels. Trinity provides a range of healthcare facilities which includes inpatient and outpatient services, managed care coverage, physician services, assisted living care, home health care, long term health care and rehabilitation services. It operates across several states with continuing care facilities, hospitals and home health and hospice programs. Trinity is headquartered in Livonia, Michigan, the US.

Trinity Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Trinity Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Trinity Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Trinity Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Trinity Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Trinity Health, Medical Devices Deals, 2012 to YTD 2018 10
Trinity Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Trinity Health, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Sharecare Raises USD25 Million in Venture Financing 12
Partnerships 13
Seven Hospitals and Three Philanthropic Foundations Form Civica RX 13
Merger 15
Catholic Health East And Trinity Health Complete Merger 15
Acquisition 17
Ascension Health Care Network To Acquire Saint Francis Care 17
Trinity Health Completes Acquisition Of Mercy Hospital & Medical Center, Healthcare Services Provider 18
Trinity Health – Key Competitors 19
Trinity Health – Key Employees 20
Trinity Health – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 22
Recent Developments 23
Strategy And Business Planning 23
Sep 06, 2018: Trinity Health and Partners take next step establishing Civica Rx a not-for-profit generic Drug company and industry disruptor 23
Sep 06, 2018: Not-for-profit generic drug company officially established, attracts interest of more than 120 health organizations 25
Financial Announcements 26
Oct 05, 2018: Trinity Health FY18 Annual Operating Income Jumps More Than 50% Over Prior Year 26
Feb 23, 2018: Trinity Health Operating Income Jumps 62% in First Half of FY18 27
Oct 27, 2017: Trinity Health excess of revenue over expenses reaches $1.3 billion to close out FY17 28
Corporate Communications 29
Aug 27, 2018: Trinity Health appoints Gay Landstrom, SVP and Chief Nursing Officer 29
Aug 21, 2018: Trinity Health appoints Michael Englehart as Senior Vice President , Medical Groups and Ambulatory Strategy 30
Aug 07, 2018: Trinity Health names Linda Ross EVP and Chief Legal Officer 31
Jul 19, 2018: Trinity Health senior communities appoints Janice Hamilton-Crawford Ppesident of its new England Region Communities 32
Apr 03, 2018: Trinity Health names Tammy Lundstrom Chief Medical Officer 33
Jan 25, 2018: Trinity Health Of New England Announces Reginald J. Eadie to be CEO 34
Nov 02, 2017: Saint Francis Healthcare names Sinnott to be President and CEO 35
Government and Public Interest 36
Oct 19, 2018: Loyola study findings could lead to treatment for heart failure in diabetes patients 36
Sep 25, 2018: Trinity Health joins in Global Fight against Antibiotic Resistance 38
Jan 18, 2018: Trinity Health and Other Leading Health Systems Join Together to Develop a Not-for-profit Generic Drug Company 39
Jan 18, 2018: Ascension joins other leading U.S. health systems to develop not-for-profit generic drug company 41
Other Significant Developments 43
Sep 24, 2018: Trinity Health Integrated Care to receive more than $12.5 M from CMS for Quality and Care Coordination Efforts 43
Jun 01, 2018: Trinity Health Launches Military and Veterans Health Program to Support Better Care, Better Health for Military and Military Families 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Trinity Health, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Trinity Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Trinity Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Trinity Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Trinity Health, Deals By Therapy Area, 2012 to YTD 2018 9
Trinity Health, Medical Devices Deals, 2012 to YTD 2018 10
Trinity Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sharecare Raises USD25 Million in Venture Financing 12
Seven Hospitals and Three Philanthropic Foundations Form Civica RX 13
Catholic Health East And Trinity Health Complete Merger 15
Ascension Health Care Network To Acquire Saint Francis Care 17
Trinity Health Completes Acquisition Of Mercy Hospital & Medical Center, Healthcare Services Provider 18
Trinity Health, Key Competitors 19
Trinity Health, Key Employees 20
Trinity Health, Subsidiaries 21
Trinity Health, Joint Venture 22

List of Figures
Trinity Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Trinity Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Trinity Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Trinity Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Trinity Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Trinity Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Trinity Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Trinity Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Trinity Health, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Trinity Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • FunPep Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary FunPep Co Ltd (FunPep) is a biotechnology venture company that focuses on the development of peptides. The company’s pipeline products include SR-0379 functional peptide and FPP003 antibody inducing peptide. It uses smart peptide research integrated technology for developing functional pepti …
  • SandRidge Energy Inc (SD):企業の財務・戦略的SWOT分析
    SandRidge Energy Inc (SD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ceylon Cold Stores PLC:企業の戦略・SWOT・財務情報
    Ceylon Cold Stores PLC - Strategy, SWOT and Corporate Finance Report Summary Ceylon Cold Stores PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SDX Energy Inc (SDX):石油・ガス:M&Aディール及び事業提携情報
    Summary SDX Energy Inc (SDX), formerly Sea Dragon Energy Inc., is an independent upstream company. It carries out the exploration, development and production of crude oil and natural gas liquids. The company’s primary areas of focus are Morocco and Egypt. Its principal operations are currently conce …
  • Knopp Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Knopp Biosciences LLC (Knopp Biosciences) is a drug discovery and development company that offers medicines for the treatment of inflammatory and neurological diseases. The company’s pipeline products include dexpramipexole and KCNQ2. Its dexpramipexole is an anti-inflammatory therapeutic fo …
  • Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Empire Energy Group Ltd (EEG):企業の財務・戦略的SWOT分析
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …
  • Samba Private Banking:企業の戦略・SWOT・財務情報
    Samba Private Banking - Strategy, SWOT and Corporate Finance Report Summary Samba Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Collegium Pharmaceutical Inc (COLL):企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DePuy Synthes Inc:医療機器:M&Aディール及び事業提携情報
    Summary DePuy Synthes Inc (DePuy Synthes), a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic and neurological procedures. DePuy Synthes operates through eight divisions: joint reconstruction, sports medicine, neurological, spine, trauma, cranio-maxi …
  • Probe Scientific Ltd-医療機器分野:企業M&A・提携分析
    Summary Probe Scientific Ltd (Probe Scientific) is a medical device company that develops products to solve clinical issues. The company offers products, which include microeye, continumon and nanoeye, among others. Its microeye is a sampling device for monitoring substances such as electrolytes, am …
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …
  • Inova Health System:医療機器:M&Aディール及び事業提携情報
    Summary Inova Health System (Inova) is a non-profit health care delivery system. It owns owns, operates and manages several research, educational, clinical and hospital facilities. It offers home health and long term care services, joint replacement services, liver disease services, mental health se …
  • Pt Bumi Resources Tbk
    Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PCI Pharma Services-製薬・医療分野:企業M&A・提携分析
    Summary PCI Pharma Services (PCI) is a drug development company that offers clinical manufacturing and packaging solutions. The company offers clinical services such as pharmaceutical development, clinical trial manufacturing, clinical trial packaging, clinical supplies management, clinical planning …
  • Genenta Science srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Genenta Science srl (Geneta Science) is a biotechnology company that develops gene therapies based on transcriptional and mirRNA-mediated controls. The company develops gene transfer strategy into autologous hematopoietic stem and progenitor cells in order to target interferon-a expression t …
  • IMPAC Mortgage Holdings Inc (IMH):企業の財務・戦略的SWOT分析
    IMPAC Mortgage Holdings Inc (IMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Dukat dd (LURA-R-A):企業の財務・戦略的SWOT分析
    Dukat dd (LURA-R-A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • DIA Imaging Analysis Ltd-医療機器分野:企業M&A・提携分析
    Summary DIA Imaging Analysis Ltd (DIA Imaging Analysis), formerly DiACardio Ltd is a healthcare technology company that offers medical imaging analysis software solutions. The company’s products comprise LVivo SWM, LVivo EF, and LVivo Strain. DiACardio’s LVivo SWM is a fully automated echo device or …
  • Bafna Pharmaceuticals Ltd (BAFNAPHARM)-製薬・医療分野:企業M&A・提携分析
    Summary Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company which manufactures and markets pharmaceutical products. The company’s operations include domestic marketing, international marketing, international export and business development. Its products comprise raricap, ra …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆